NCT02929017

Brief Summary

Patients with Idiopathic Pulmonary Fibrosis (IPF) and their caregivers will be randomized to receive this intervention or usual care. The intervention will include information about the disease, self-management strategies, and introduction to advanced care planning in a format with enhanced content available across multiple domains (face-to-face, printed material, digital (tablet) delivered by an interventionist. The usual care group will be provided with routine printed patient education. At the end of life, IPF patients and their caregivers experience stress, symptom burden, poor quality of life, and inadequate preparedness for end-of-life care planning. The proposed study will measure feasibility, acceptability, and impact of a Supportive Care intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 10, 2016

Completed
5 months until next milestone

Study Start

First participant enrolled

March 23, 2017

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 24, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 24, 2020

Completed
Last Updated

August 7, 2020

Status Verified

August 1, 2020

Enrollment Period

3.3 years

First QC Date

October 6, 2016

Last Update Submit

August 6, 2020

Conditions

Keywords

Idiopathic Pulmonary FibrosisFibrosisIPFCaregiversPulmonaryPalliativeend of lifeIdiopathic

Outcome Measures

Primary Outcomes (1)

  • Stress

    Perceived Stress Scale at baseline and completion of study in patients and caregivers

    3 years

Secondary Outcomes (6)

  • Disease Preparedness

    3 years

  • Knowledge

    3 years

  • Advance Care Planning

    3 years

  • Quality of Dying and Death

    3 years

  • Symptom Burden

    3 years

  • +1 more secondary outcomes

Study Arms (2)

Intervention

OTHER

Group will receive SUPPORT, an intervention that provides information about the disease, self-management strategies, and introduction to advanced care planning in a format with enhanced content available across multiple domains (face-to-face, printed material, and digitally (via use of a tablet) delivered by an interventionist.

Other: SUPPORT

Usual Care

OTHER

Group will receive usual standard-of-care, and be provided with currently available printed material for information about their illness.

Other: Currently Available Printed Material

Interventions

SUPPORTOTHER

Members of this group will receive personal, enhanced printed materials, as well as face-to-face support, and digital information provided by the interventionist.

Intervention

Subjects will receive their usual standard of care, including currently available printed patient material.

Also known as: Usual Standard of Care
Usual Care

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • Primary Diagnosis of with Idiopathic Pulmonary Fibrosis (IPF)
  • Has a caregiver, 18 years or older (spouse/partner/child/family member/friend), willing to participate.
  • Sees a Simmons Center Physician for usual IPF care.

You may not qualify if:

  • less than 45 years
  • Not diagnosed with IPF
  • Has an unwilling caregiver, or a caregiver under 18.
  • Does not see a Simmons Center Physician for usual IPF care.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease

Pittsburgh, Pennsylvania, 15213, United States

Location

Related Publications (2)

  • Lindell KO, Klein SJ, Veatch MS, Gibson KF, Kass DJ, Nouraie M, Rosenzweig MQ. Nurse-Led Palliative Care Clinical Trial Improves Knowledge and Preparedness in Caregivers of Patients with Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc. 2021 Nov;18(11):1811-1821. doi: 10.1513/AnnalsATS.202012-1494OC.

  • Lindell KO, Nouraie M, Klesen MJ, Klein S, Gibson KF, Kass DJ, Rosenzweig MQ. Randomised clinical trial of an early palliative care intervention (SUPPORT) for patients with idiopathic pulmonary fibrosis (IPF) and their caregivers: protocol and key design considerations. BMJ Open Respir Res. 2018 Feb 19;5(1):e000272. doi: 10.1136/bmjresp-2017-000272. eCollection 2018.

MeSH Terms

Conditions

Idiopathic Pulmonary FibrosisFibrosisDeath

Interventions

Palliative Care

Condition Hierarchy (Ancestors)

Pulmonary FibrosisLung Diseases, InterstitialLung DiseasesRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Patient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Kathleen O Lindell, PhD, RN

    Dorothy P. and Richard P. Simmons Center for ILD

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor of Medicine

Study Record Dates

First Submitted

October 6, 2016

First Posted

October 10, 2016

Study Start

March 23, 2017

Primary Completion

June 24, 2020

Study Completion

June 24, 2020

Last Updated

August 7, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations